Drug Research
Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services
Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth...
News
Metrics Contract Services Successfully Completes ANVISA Regulatory Inspection
Metrics Contract Services, a division of Mayne Pharma, is pleased to announce that its Greenville, North Carolina facility has successfully completed an inspection by...
Packaging & Labelling
Syntegon enters strategic partnership with Bayer
Syntegon (formerly Bosch Packaging Technology), has entered a strategic partnershop with Bayer for the development of new continuous manufacturing processes for oral solid dosage...
News
Clinerion Patient Network Explorer technology used by the SPHN to enable feasibility queries on clinical data across all five of Switzerland’s university hospitals simultaneously
Clinerion Patient Network Explorer technology powers the Federated Query System (FQS) of the Swiss Personalized Health Network (SPHN), which operates across all five of...
News
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval
AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on...
Press Releases
Roche’s Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
Roche announced that the European Commission has granted a marketing authorisation for Ronapreve™ (casirivimab and imdevimab), for treating COVID-19 in adults and adolescents (from...
Press Releases
Regeneron Antibody Cocktail Approved by European Commission to Treat and Prevent COVID-19
Regeneron Pharmaceuticals, Inc. announced that the EC has approved the casirivimab and imdevimab antibody cocktail, known as REGEN-COV® in the U.S. and Ronapreve™ in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read